Expert Interviews

Emerging Targeted Therapies in Bladder Cancer: Frontline Options and Beyond
GU Oncology Now spoke with Arlene O. Siefker-Radtke, MD, of the Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, regarding the current and novel targeted therapies entering the market for bladder cancer—in the frontline setting and throughout the treatment continuum—as well as how these agents are being assessed in combination approaches. ...
Advertisement
Advertisement

Featured Knowledge Hubs

Prostate Cancer
Prostate Cancer
Advertisement
Advertisement